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Introduction
Haspin (also known as germ cell–specific gene 2 protein/GSG2 
or haploid germ cell–specific nuclear protein kinase) is a serine/
threonine kinase. Its overall fold conforms to the eukaryotic 
protein kinase (ePK) domain, but diverges in crucial ways from 
typical ePK members. Accordingly, Haspin is often classified as 
an atypical ePK family member (Tanaka et al., 1999; Higgins, 
2001; Eswaran et al., 2009; Villa et al., 2009). Haspin’s best-
characterized and conserved function to date is exercised at 
centromeres (Higgins, 2010). Centromeres are genetic loci that 
mark the site of construction of kinetochores, structures that 
mediate the interaction of chromosomes with spindle micro-
tubules during mitosis (Tanaka et al., 1999; Higgins, 2001; 
Eswaran et al., 2009; Santaguida and Musacchio, 2009; Villa 
et al., 2009). Haspin phosphorylates histone H3 on threonine 3 
(P-T3-H3), a phosphomark that accumulates specifically at 
centromeres during prometaphase (Polioudaki et al., 2004; 
Dai et al., 2005; Markaki et al., 2009; Higgins, 2010). P-T3-H3 
is dephosphorylated after anaphase by the PP1 phosphatase 
with the contribution of the PP1 regulator Repo-Man (Qian 
et al., 2011).
Ablation of Haspin by RNAi perturbs chromosome bi-
orientation and sister chromatid cohesion (Dai et al., 2005, 
2006; Markaki et al., 2009; Higgins, 2010). These consequences 
of Haspin inhibition might reflect impaired centromeric local-
ization of the chromosome passenger complex (CPC; Kelly 
et al., 2010; Wang et al., 2010; Yamagishi et al., 2010). The CPC 
is a complex of the four subunits Survivin, Borealin, INCENP, 
and Aurora B. The latter, also a serine/threonine kinase, regu-
lates aspects of mitotic progression including chromosome 
condensation and bi-orientation, the spindle assembly check-
point (SAC), and cytokinesis (Ruchaud et al., 2007).
Two related pathways mediate centromere recruitment of 
the CPC. First, Bub1-dependent phosphorylation of histone 
H2A at Thr120 is proposed to create a binding site for Borealin 
through Shugoshin (Kawashima et al., 2010; Tsukahara et al., 
2010; Storchová et al., 2011; van der Waal et al., 2012a). Sec-
ond, Survivin binds directly to P-T3-H3 in the context of the 
N-terminal tail of histone H3 (Tanaka et al., 1999; Higgins, 2001; 
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kinetochore subunits Hec1/Ndc80, Dsn1, and Knl1/Spc105, 
and the microtubule regulators MCAK and CENP-E (Ruchaud 
et al., 2007; Qian et al., 2011; van der Waal et al., 2012b). 
Aurora B is also required for kinetochore recruitment and opti-
mal activity of several SAC proteins (Ditchfield et al., 2003; Hauf 
et al., 2003; Vigneron et al., 2004; Dai et al., 2005, 2006; 
Markaki et al., 2009; Becker et al., 2010; Higgins, 2010; 
Santaguida et al., 2011; Saurin et al., 2011; Matson et al., 2012). 
Furthermore, Aurora B activity might counteract the kineto-
chore localization of the PP1 phosphatase, which opposes 
SAC signaling (Lampson and Cheeseman, 2011; Lesage 
et al., 2011).
Depletion of Haspin prevented CPC recruitment to centro-
meres (Kelly et al., 2010; Wang et al., 2010; Yamagishi et al., 
2010). This in turn correlated with chromosome bi-orientation 
Eswaran et al., 2009; Villa et al., 2009; Kelly et al., 2010; 
Wang et al., 2010; Yamagishi et al., 2010; Jeyaprakash et al., 
2011; Qian et al., 2011; F. Wang et al., 2011; Du et al., 2012; 
Niedzialkowska et al., 2012). Thus, by phosphorylating T3-H3, 
Haspin promotes phosphorylation-dependent centromeric re-
cruitment of the CPC (Fig. 1 A).
Aurora B generates additional mitotic phosphomarks 
on histones or histone variants by targeting Ser10 on histone 
H3 (P-S10-H3) along chromosome arms (Hsu et al., 2000; 
Giet and Glover, 2001; Higgins, 2010) and Ser7 of CENP-A 
(P-S7-CENP-A) Zeitlin et al., 2001b; Santaguida and Musacchio, 
2009), the centromeric variant of histone H3 (Polioudaki et al., 
2004; Dai et al., 2005; Markaki et al., 2009; Santaguida and 
Musacchio, 2009). Aurora B phosphorylates additional sub-
strates at the centromere and kinetochores, including the 
Figure 1. 5-ITu inhibits histone 3 Thr3 phosphorylation. (A) Schematic representation of CPC recruitment to centromeres. Haspin phosphorylates T3-H3 
at centromeres. Survivin (Sur), a CPC subunit, recognizes P-T3-H3, promoting recruitment of other CPC subunits. 5-ITu has been shown to inhibit Haspin 
in vitro (Villa et al., 2009; Eswaran et al., 2009). (B) HeLa cells were released from a double-thymidine arrest. After 5 h, nocodazole (3.3 µM) and the 
indicated concentrations of 5-ITu were added. After 2 h, 10 µM MG132 was added to prevent mitotic exit. After 90 min, cells were harvested, processed 
for immunofluorescence, and stained with DAPI (DNA), CREST sera (kinetochores), and an antibody against phosphorylated threonine 3 of histone H3 
(P-T3-H3). Bar, 5 µm. (C) Quantitation of data from the experiment illustrated in B. Graphs report mean ± SEM. Data were normalized to the indicated 
control ratio. Details of quantitation are to be found in Materials and methods. (D) HeLa cells were treated as in B. Two Aurora B inhibitors (Hesperadin 
and ZM447439) were tested and their effect on the levels of P-T3-H3 compared. Bar, 5 µm. (E) Quantitation of data from the experiment illustrated in D. 
Graphs report mean ± SEM. Data were normalized to the indicated control ratio. (F) HeLa cells were treated with 3.3 µM nocodazole, and after 6 h mitotic 
cells were isolated by mitotic shake-off. Cells were replated in 10 µM MG132, and after 30 min the indicated inhibitors were added. After 90 min, cells 
were harvested and processed for immunofluorescence. Bar, 10 µm.
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Aurora A–TPX2, Aurora B–INCENP, Bub1, Cdk1/Cyclin B, 
Mps1, Plk1, and Nek2A (Balzano et al., 2011), the selectivity 
data generated against a large panel of kinases with distinct 
screening methodologies identifies 5-ITu as an attractive chem-
ical tool for targeting Haspin.
5-ITu inhibits histone 3 Thr3 
phosphorylation
To test if 5-ITu inhibits Haspin in vivo, we applied growing 
concentrations of 5-ITu to HeLa cells. Incubation with high 
concentrations of 5-ITu at early stages of the cell cycle can in-
hibit the entry of HeLa cells into mitosis. To avoid this prob-
lem, whose causes are unclear but likely caused by inhibition 
of one or more interphase targets of Haspin, we directed our 
analysis to cells that were already in mitosis at the time of ad-
dition of 5-ITu.
At concentrations between 0.1 and 0.5 µM, 5-ITu caused 
a strong decrease in the immunofluorescence levels of P-T3-H3 
(Fig. S1). Depletion of P-T3-H3 was complete at 10 µM 5-ITu 
(Figs. 1 B and S1 A, quantitation in Fig. 1 C). A 50% reduction 
in the levels of P-T3-H3 was also observed when cells were 
treated with the Aurora B inhibitors Hesperadin and ZM447439 
(Fig. 1, D and E, and Fig. S1 D), in agreement with a previous 
report (F. Wang et al., 2011). The relatively high concentra-
tions of 5-ITu required for ablating P-T3-H3 may appear to 
contrast with the efficacy of the compound on Haspin in vitro 
(IC50 = 9 nM; Balzano et al., 2011). This behavior likely re-
flects the rather hydrophilic character of 5-ITu, whose parti-
tion coefficient, reported in PubChem (http://pubchem.ncbi 
.nlm.nih.gov), is 0.7, in comparison with values of 3.9, 4.2, 
and 4.2 for more lipophilic compounds such as Reversine, Hes-
peradin, and ZM447439, respectively.
To rule out down-regulation of P-T3-H3 levels by 5-ITu 
inhibition of adenosine kinase we tested the potent adenosine 
kinase inhibitor ABT-702 (IC50 = 1.7 nM; Lee et al., 2012). The 
mitotic levels of P-T3-H3 remained normal at ABT-702 con-
centrations as high as 5 µM, excluding effects mediated by ade-
nosine kinase on P-T3-H3 phosphorylation levels (Fig. 1 F).
5-ITu displaces the CPC from centromeres
P-T3-H3 promotes localization of the CPC in human cells 
and in frog extracts through a direct interaction with Survivin 
(Kelly et al., 2010; Wang et al., 2010; Yamagishi et al., 2010; 
Jeyaprakash et al., 2011; Du et al., 2012; Niedzialkowska 
et al., 2012). We tested if treatment with 5-ITu, by prevent-
ing the accumulation of P-T3-H3, displaced the CPC from 
centromeres. Indeed, 5-ITu caused dose-dependent displace-
ment of the CPC subunits Borealin and Aurora B from cen-
tromeres, and their apparent relocalization to chromosome 
arms (Fig. 2, A and B; and Fig. S1 B). The analysis of chro-
mosome spreads emphasized the strong reduction of centro-
meric P-T3-H3 and the mislocalization of Aurora B in 5-ITu 
(Fig. 2, C and D).
Contrarily to these extensive effects on CPC localiza-
tion, inhibition of Aurora B with Hesperadin caused a rela-
tively modest displacement of CPC subunits from centromeres 
and relocalization to chromosome arms (Fig. 2, A and B, and 
defects, possibly through deregulation of mitotic centromere 
associated kinesin (MCAK; Wang et al., 2010). However, 
other landmarks of centromeric localization of Aurora B, such 
as P-S7-CENP-A, were only modestly impaired (Wang et al., 
2010). Similarly, SAC function was also modestly impaired in 
cells in which Haspin function was inhibited by RNAi (Wang 
et al., 2010). It is unclear whether the relatively modest conse-
quences of repressing Haspin by RNAi are due to limited pen-
etrance of the targeting approach, or alternatively to the ability 
of the CPC to control kinetochore and centromere function 
through a soluble pool that is not affected by inhibition of 
Haspin. Arguing against the second alternative, previous anal-
yses have suggested that Aurora B concentration at centromeres 
or kinetochores might be important for its activation (Kelly 
et al., 2007; Rosasco-Nitcher et al., 2008; DeLuca et al., 2011; 
E. Wang et al., 2011).
Here, we further investigated the role of Haspin in the 
regulation of the CPC by means of a small-molecule ATP-
competitive Haspin inhibitor, 5-iodotubercidin (5-Iodo-7--d-
ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, abbreviated 
as 5-ITu). 5-ITu was originally characterized as an inhibitor 
of adenosine kinase (Wotring and Townsend, 1979; Newby, 
1981), but was later shown to target protein kinases as well 
(Massillon et al., 1994). We and others recently demonstrated 
that 5-ITu is a potent and selective Haspin inhibitor in vitro 
(Fedorov et al., 2007; Eswaran et al., 2009; Balzano et al., 
2011). Because the potential of 5-ITu as a Haspin inhibitor 
in living cells has not been assessed, we set out to test its function 
in human cells.
Results
5-ITu is a specific Haspin inhibitor
5-ITu potently targets the ATP-binding site of Haspin (IC50 
5–9 nM; Eswaran et al., 2009; Balzano et al., 2011). To evaluate 
its selectivity, we screened 5-ITu against a commercial panel 
of 180 protein kinases at two inhibitor concentrations (0.1 and 
1.0 µM; Table S1). 5-ITu had significant cross-reactivity with 
only a small number of kinases in this panel (Table S1, high-
lighted in red), including the members of the CMGC kinase 
family CLK (Cdc2-like kinase) and DYRK (dual-specificity 
tyrosine (Y) regulated kinase). Modest cross-reactivity was 
observed for another relatively small set of kinases (high-
lighted in yellow), including Cdk1/Cyclin B. The selectivity 
screening data also showed that 5-ITu is inactive against all 
three human Aurora kinases. In addition, we screened 5-ITu 
against 117 highly diverse kinases using temperature shift 
(Tm) assays (Fedorov et al., 2012; Table S2). This assay 
measures the affinity of inhibitors indirectly through the in-
crease in protein stability upon binding. Tm data typically 
correlate well with enzymatic assay data (Fedorov et al., 
2011). Tm values larger than 6°C typically indicate inhibitors 
with nM potency. The Tm screening data confirmed the 
cross-reactivity of 5-ITu against CLK and DYRK and detected 
only weak Tm shifts for all protein kinases screened. To-
gether with our previous in vitro kinase assays, in which we 
proved that 5-ITu at 1-µM concentration is inactive against 
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Figure 2. 5-ITu displaces the CPC from centromeres. (A) Cells treated as in Fig. 1 B were supplemented with the indicated inhibitors and processed for 
immunofluorescence. Bar, 5 µm. (B) Quantitation of data shown in A. Localization of Aurora B and Borealin was analyzed for the indicated number of cells. 
Graphs report mean ± SEM. (C and D) Cultures of GFP-Aurora B HeLa cells were treated with 3.3 µM nocodazole for 12 h, after which 10 µM MG132 
was added for 30 min. After a 90-min incubation with 10 µM 5-ITu, the mitotic population was isolated by mitotic shake-off and cells were prepared for 
immunofluorescence. Chromosome spreads were processed to visualize DAPI, CREST, P-T3-H3, and GFP-Aurora B. For presentation purposes, the P-T3-H3 
and GFP-Aurora B signals are shown in two distinct panels with the same DAPI and CREST staining. Bar, 2 µm (insets, 1 µM). (E) HeLa cells were released 
from a double-thymidine arrest. After 6.5 h, the indicated inhibitors were added. After 30 min, 10 µM MG132 was added and after 90 min cells were har-
vested and processed for immunofluorescence. Bar, 5 µm. All images in this panel were acquired within the same experiment. (F) Quantitation of data from 
the experiment in E. The indicated number of cells for each condition was scrutinized for chromosome alignment defects. Graphs report mean ± SEM.
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5-ITu affects Aurora B activity at  
inner kinetochores
Serine 7 of CENP-A is a kinetochore substrate of Aurora B 
(Zeitlin et al., 2001a,b). The levels of this phosphomark at the 
inner kinetochore were only largely affected at 5-ITu concentra-
tions comprised between 5 and 10 µM (Fig. 3, A and B). When 
considering that 5-ITu causes substantial reductions in the levels 
of P-T3-H3 already at 1 µM, this observation suggests the possi-
bility that small residual levels of Aurora B are sufficient for the 
phosphorylation of kinetochore substrates of this kinase.
By comparison, the levels of phosphorylated serine 10 of 
histone 3 (P-S10-H3), another substrate of Aurora B localizing 
all along chromosome arms (Gurley et al., 1978; Paulson and 
Taylor, 1982), remained apparently constant in experiments of 
indirect immunofluorescence (see Fig. S2 and Discussion). Thus, 
Aurora B activity at the inner kinetochore is strongly impaired 
Fig. S1, B and C). Thus, Aurora B activates Haspin by phos-
phorylation to enhance T3-H3 phosphorylation and to promote 
its own recruitment to the centromere (F. Wang et al., 2011), 
but its inhibition does not reduce the levels of P-T3-H3 to the 
point of preventing centromeric localization of the CPC.
In agreement with the extensive effects of 5-ITu on 
Aurora B localization, HeLa cells treated with 5-ITu displayed 
significant defects in sister chromatid bi-orientation. At 1 µM 
5-ITu most chromosomes congressed to the metaphase plate, 
but the plates often appeared broader and less focused (Fig. 2, 
E and F; and Fig. S1 D). At 5 µM 5-ITu a metaphase plate was 
still recognizable, but a large proportion of chromosomes failed 
to align at the equator and remained stuck near the poles, indic-
ative of bi-orientation problems. These observations are in line 
with the previously described phenotype of RNAi-based abla-
tion of Haspin (Dai et al., 2005, 2006).
Figure 3. 5-ITu affects Aurora B activity at inner kinetochores. (A) HeLa cells were released from a double-thymidine arrest and after 5 h, 3.3 µM no-
codazole and the indicated inhibitors were added. After 2 h, 10 µM MG132 was added to prevent mitotic exit by the inhibitors. After 90 min, cells were 
harvested, processed for immunofluorescence, and stained with DAPI (DNA), CREST sera (kinetochores), and antibodies against P-S10-H3 and P-S7–CENP-A; 
respectively, chromatin- and kinetochore-based substrates of Aurora B. Bar, 5 µm. (B) Quantitation of data from the experiment in A. Graphs represent 
mean ± SEM. Data were normalized to the indicated control ratio. (C) HeLa cells were treated with 3.3 µM nocodazole for 12 h. Nocodazole was washed 
out with or without the indicated inhibitors and mitotic cells were imaged during mitotic exit to monitor cytokinesis. (D) Kinetochore levels of Hec1 were not 
affected by 10 µM 5-ITu. Bar, 5 µm. (E) Quantitation of data from the experiment illustrated in D. Graphs represent mean ± SEM. Data were normalized 
to the indicated control ratio.
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absence of other agents, OKA caused an 50% reduction in 
the centromeric levels of Aurora B, in agreement with a pre-
vious report (Takemoto et al., 2009).
Addition of OKA did not restore P-T3-H3, suggesting 
that 5-ITu achieves a very penetrant inhibition of Haspin that 
cannot be reverted even if PP1 (known to target P-T3-H3 for 
dephosphorylation; Qian et al., 2011) is inhibited (Fig. 4 F). 
Accordingly, Aurora B remained mislocalized when 5-ITu and 
OKA were used in combination (Fig. 4, A and F). Conversely, 
inhibition of Aurora B with 1 µM Hesperadin did not result in 
Aurora B mislocalization, and concomitant inhibition of phos-
phatase activity did not promote the recovery of Bub1 or BubR1 
kinetochore localization (Fig. 4, A–D). Thus, kinetochore re-
cruitment of Bub1 and BubR1 requires Aurora B activity, and 
such activity needs to be delivered near centromeres and ki-
netochores. The residual Aurora B activity observed in cells 
treated with Haspin inhibitors is sufficient to execute cytoki-
nesis but might be insufficient for kinetochore accumulation 
of Bub1 and BubR1 (unless phosphatase activity is concomi-
tantly inhibited). These results are consistent with the hypothe-
sis of a reciprocal regulation of Aurora B and phosphatase activity 
at centromeres (Emanuele et al., 2008; Pinsky et al., 2009; 
Vanoosthuyse and Hardwick, 2009a,b; Kim et al., 2010; Liu 
et al., 2010; Posch et al., 2010; Foley et al., 2011; Lesage et al., 
2011; Meadows et al., 2011; Qian et al., 2011; Rosenberg et al., 
2011; London et al., 2012; Shepperd et al., 2012).
Forcing Aurora B localization at 
centromeres restores P-S7–CENP-A and 
kinetochore localization of SAC proteins
Insufficient Aurora B activity at centromeres and kinetochores 
in cells treated with 5-ITu likely is the cause of reduced kineto-
chore accumulation of P-S7–CENP-A, Bub1, and BubR1. To 
substantiate this idea, we forced localization of Aurora B to 
inner kinetochores by expressing a construct in which a frag-
ment of INCENP containing the Aurora B binding site but 
devoid of the centromere-targeting domain (INCENP48–918) is 
fused to the C terminus of the DNA-binding domain of CENP-B 
(CENP-B1–158), an inner kinetochore protein (Liu et al., 2009). 
Transfection of this construct can be visualized via a GFP moi-
ety fused to the C terminus of the CENP-B–INCENP fusion. 
We introduced three point mutations in the DNA-binding do-
main of CENP-B (Arg5-Ala, Lys70-Ala, Arg125-Ala, abbrevi-
ated as CENP-BAAA–INCENP) to generate a negative control.
The CENP-B–INCENP fusion correctly targeted kineto-
chores in the presence of 5-ITu, but as expected given the con-
tinued inhibition of Haspin, it failed to restore the P-T3-H3 
signal (Fig. 5, A and B; yellow arrowheads indicate cells 
transfected with the CENP-B–INCENP construct, and white 
arrowheads indicate untransfected control cells). The chimera, 
however, drove Aurora B accumulation at kinetochores despite 
5-ITu (Fig. 5, C and D), indicating that the CENP-B–INCENP 
fusion binds to Aurora B and can overcome the loss of P-T3-H3. 
Such accumulation was strictly dependent on the DNA-binding 
domain of CENP-B, because a CENP-BAAA–INCENP fusion 
failed to rescue kinetochore accumulation of Aurora B (Fig. 5, 
E and F, right). Indeed, expression of the mutant chimera had a 
upon addition of 10 µM 5-ITu. Furthermore, 5-ITu might cause 
a more global reduction in Aurora B activity with effects ex-
tending beyond the centromere and kinetochores, possibly to 
chromosome arms and other regions of the cell (Lampson and 
Cheeseman, 2011; Tan and Kapoor, 2011; E. Wang et al., 2011). 
To investigate this important point, we asked if the cellular lev-
els of Aurora B activity in the presence of 10 µM 5-ITu were 
sufficient to complete cytokinesis, the most inhibitor-sensitive 
function of Aurora B (Santaguida et al., 2010; Xu et al., 2010). 
Cytokinesis in the presence of 5-ITu was essentially normal 
(Fig. 3 C), indicating that 5-ITu at 10-µM concentration does 
not cause strong global inhibition of Aurora B. Moreover, 10 µM 
5-ITu did not cause obvious defects in kinetochore assembly 
because the outer kinetochore protein Hec1/Ndc80 localized 
normally (Fig. 3, D and E).
Effects of 5-ITu on the recruitment  
of checkpoint proteins
We next asked if 5-ITu perturbed kinetochore recruitment 
of SAC components, which depends on Aurora B (Ditchfield 
et al., 2003; Hauf et al., 2003; Vigneron et al., 2004). To sim-
plify the interpretation of our results, we used a concentration 
of nocodazole (3.3 µM) previously shown to cause apparently 
complete microtubule depolymerization (Yang et al., 2009; 
Santaguida et al., 2011). In cells treated with 5-ITu, two mi-
totic checkpoint components, Bub1 and BubR1, were partially 
displaced from kinetochores (Fig. 4, A–D). Furthermore, 
5-ITu treatment resulted in levels of Bub1 dephosphorylation 
comparable to those of cells treated with doses of the Aurora B 
inhibitor Hesperadin (1 µM) that have strong deleterious ef-
fects on the SAC (Fig. 4 E). Inhibition of Aurora B kinase 
with Hesperadin also prevented kinetochore localization of 
Bub1 and BubR1 (Fig. 4, A–D), in agreement with previous 
studies (Ditchfield et al., 2003; Vigneron et al., 2004). Collec-
tively, these observations are consistent with the hypothesis 
that centromere- and kinetochore-localized Aurora B activity is 
important for kinetochore recruitment of Bub1 and BubR1, pos-
sibly through a pathway centered on Mps1 (London et al., 2012; 
Shepperd et al., 2012; van der Waal et al., 2012a; Yamagishi 
et al., 2012).
Several recent reports demonstrated mutual regulation 
of Aurora B and protein phosphatase activity at centromeres 
and kinetochores (Emanuele et al., 2008; Pinsky et al., 2009; 
Vanoosthuyse and Hardwick, 2009a,b; Kim et al., 2010; Liu 
et al., 2010; Posch et al., 2010; Foley et al., 2011; Lesage et al., 
2011; Meadows et al., 2011; Qian et al., 2011; Rosenberg 
et al., 2011; London et al., 2012; Shepperd et al., 2012). We 
reasoned that in the absence of centromere- and kinetochore-
localized Aurora B, phosphatase activity might become de-
regulated, preventing the accumulation of phosphorylated 
substrates of Aurora B. To test this model, we asked if the 
PP1 and PP2 inhibitor okadaic acid (OKA, used at 0.5–1-µM 
concentrations) allowed Bub1 or BubR1 to accumulate at 
kinetochores despite the treatment with 10 µM 5-ITu. Indeed, 
OKA reverted the adverse effects of 5-ITu on the localization of 
Bub1 and BubR1 (Fig. 4, A–D). OKA also opposed the de-
phosphorylation of Bub1 caused by 5-ITu (Fig. 4 E). In the 
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Figure 4. Effects of 5-ITu on recruitment of checkpoint proteins. (A) Asynchronously growing HeLa cells were treated with 3.3 µM nocodazole. After 6 h 
mitotic cells were isolated by mitotic shake-off. Cells were replated in 10 µM MG132, and after 30 min the indicated concentrations and combinations of 
inhibitors were added. Cells were fixed after 90 min and processed for immunofluorescence with DAPI (DNA), CREST sera (kinetochores), and antibodies 
against Aurora B and Bub1. Bar, 10 µm. (B) Quantitation of data from the experiment illustrated in A. Graphs report mean ± SEM. Data were normalized 
to the indicated control ratio. The histograms were color coded to match the colored squares in A, with each color referring to the condition associated 
with the square. (C) As in A, but monitoring localization of BubR1 instead of Bub1. (D) Quantitation of data from the experiment in C. Graphs report 
mean ± SEM. Data were normalized to control ratio. Color coding is as explained in B. (E) Asynchronously growing HeLa cells were treated with 3.3 µM 
nocodazole for 6 h. Mitotic cells were collected by shake-off and treated with the indicated inhibitors complemented with 10 µM MG132 to prevent mitotic 
exit in the presence of the inhibitors. The mobility of Bub1 was evaluated by Western blotting after SDS-PAGE with 7.5% acrylamide gel (with an 80:1 
acrylamide/bis-acrylamide ratio). (F) Chromosome spreads were generated as for Fig. 2 (C and D). On the left, the control and 5-ITu spreads are the same 
shown in Fig. 2 (C and D). Spreads were obtained in the same experiment. Bar, 2 µm.
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Next, we tested if the CENP-B–INCENP fusion was able to 
support kinetochore accumulation of the P-S7–CENP-A phos-
phoantigen in the presence of 10 µM 5-ITu. Indeed, CENP-B–
INCENP promoted substantial reaccumulation of P-S7–CENP-A 
despite the continued presence of 5-ITu (Fig. 5, G and H). This 
effect was strictly dependent on kinetochore localization of the 
chimera because the triple mutant in the CENP-B DNA-binding 
dominant-negative effect on kinetochore accumulation of Aurora B 
even in the absence of 5-ITu, probably because it subtracts 
Aurora B from endogenous INCENP, preventing its localization 
to centromeres. Conversely, wild-type CENP-B–INCENP caused 
an increase in the levels of Aurora B in the centromere/kineto-
chore area in comparison to the endogenous levels measured in 
cells not expressing the construct (Fig. S4 A).
Figure 5. Forcing Aurora B localization at 
centromeres restores P-S7–CENP-A and kineto-
chore localization of SAC proteins. (A, C, E, 
G, I, and M) HeLa cells were transfected with 
CENP-B–INCENP-GFP or CENP-BAAA–INCENP-
GFP fusion construct for 24–48 h. Cells were 
subsequently treated with 3.3 µM nocodazole. 
After 6 h mitotic cells were isolated by mitotic 
shake-off, replated in 10 µM MG132, and 
after 30 min 5-ITu (at 10 µM) was added. Cells 
were harvested after 90 min and processed for 
immunofluorescence to visualize DAPI (DNA), 
CREST (kinetochores), GFP, and the indicated 
antigens. Bar, 10 µm. (B, D, F, H, L, and N) 
Quantitation of data from the experiment illus-
trated in A, C, E, G, I, and M, respectively. 
Graphs report mean ± SEM. Data were nor-
malized to the respective indicated control 
ratio, except in F and L, where normalization 
was performed against the untransfected con-
trol because the expression of the CENP-BAAA–
INCENP-GFP fusion has a dominant-negative 
effect on Aurora B localization even in the 
absence of 5-ITu. Note that CREST signal in-
creases in cells expressing CENP-B–INCENP-
GFP due to reactivity of CREST to CENP-B.
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chimera in the absence of spindle poisons. This effect, which 
has been discussed before, is probably caused by alignment er-
rors after relocalization of Aurora B close to the outer kineto-
chores (Liu et al., 2009). Cells expressing the CENP-B–INCENP 
chimera and control cells were first arrested in nocodazole. 
Nocodazole was then washed out, and the time of anaphase 
onset was monitored by time-lapse video microscopy. Control 
cells underwent anaphase at 79 ± 57 min, whereas cells express-
ing CENP-B–INCENP underwent anaphase at 250 ± 148 min 
(Fig. 7 B), confirming that expression of CENP-B–INCENP 
causes a mitotic arrest in otherwise normally dividing cells. 
We therefore asked if 5-ITu was able to override such arrest. 
As a control, we used Reversine, a small-molecule ATP-
competitive inhibitor of Mps1 (Santaguida et al., 2010). Both 
Reversine and 5-ITu abrogated the mitotic arrest caused by 
domain abrogated it (Fig. 5, I–L). Also in this case, wild-type 
CENP-B–INCENP increased the levels of P-S7–CENP-A 
in comparison to the endogenous levels, and such increase cor-
related with the increased levels of Aurora B (Fig. S4 B). 
Finally, cells expressing CENP-B–INCENP also had apparently 
normal levels of kinetochore BubR1 or Bub1 (Fig. 5, M and N; 
and Fig. S3) despite 5-ITu.
Overall, these observations indicate that localization 
of Aurora B activity at centromeres promoted by Haspin via 
P-T3-H3 is essential for Aurora B–mediated phosphorylation 
of kinetochore substrates and for checkpoint function. Forced 
localization of Aurora B activity at kinetochores or inhibition 
of phosphatases that oppose Aurora B activity at kinetochores 
is sufficient to restore the phosphorylation status of substrates 
or the localization of SAC components.
5-ITu affects Aurora B activity on the 
outer kinetochore
An 80-residue N-terminal segment of Hec1/Ndc80 is important 
for kinetochore–microtubule binding and is a well-established 
prometaphase target of Aurora B (Ciferri et al., 2005; Cheeseman 
et al., 2006; DeLuca et al., 2006, 2011; Guimaraes et al., 2008; 
Miller et al., 2008; Welburn et al., 2010). We tested if 5-ITu 
suppressed the accumulation of the phosphorylated form of 
Ser44 of Hec1/Ndc80 (P-S44-Hec1), which depends on Aurora B 
(Cheeseman et al., 2006; DeLuca et al., 2006, 2011; Ciferri et al., 
2008). Indeed, 5-ITu caused an 50% reduction in the kineto-
chore levels of P-S44-Hec1 (Fig. 6, A and B). This effect was in-
ferior to that caused by direct inhibition of Aurora B kinase with 
Hesperadin. However, contrarily to the latter, it was rescued by 
the CENP-B–INCENP construct (Fig. 6, A and B), suggesting 
that the accumulation of normal levels of P-S44-Hec1 at kineto-
chores requires Aurora B activity locally.
Effects of 5-ITu on the spindle  
assembly checkpoint
Kinetochore recruitment of SAC proteins is considered impor-
tant for optimal checkpoint operation (Musacchio and Salmon, 
2007). Because 5-ITu appeared to affect kinetochore recruit-
ment of at least two SAC proteins, we asked if cells challenged 
with 5-ITu were able to maintain a checkpoint-dependent arrest 
in mitosis. We therefore tested the effects of 5-ITu on the SAC 
in two distinct assays. First, we generated a population of 
mitotic cells by mitotic shake-off of cycling cells treated with 
3.3 µM nocodazole for 6 h. Control cells maintained the arrest 
for at least 11 h (Fig. 7 A). Conversely, cells treated with 5-ITu 
underwent checkpoint override at times that depended on 
drug concentration, with effects that became evident between 
0.5 and 1.0 µM (Fig. 7 A and Fig. S5). At 10 µM, the adverse 
effect of 5-ITu on checkpoint duration was as pervasive as 
that caused by 1 µM Hesperadin (Fig. S5). As a positive con-
trol for these experiments, we also monitored the effects of 
the Cdk1 inhibitor flavopiridol (Losiewicz et al., 1994), which 
caused mitotic exit in less than 2 h at 1-µM or higher concen-
trations (Fig. 7 A).
Second, we asked if 5-ITu was able to override the 
SAC arrest caused by expression of the CENP-B–INCENP 
Figure 6. 5-ITu affects Aurora B activity on the outer kinetochore.  
(A) HeLa cells were transfected with CENP-B–INCENP-GFP fusion construct 
for 24–48 h. Cells were subsequently treated with 3.3 µM nocodazole. 
After 6 h, 10 µM MG132 was added, and after 30 min 10 µM 5-ITu was 
added. Cells were fixed after 90 min and processed for immunofluores-
cence to visualize DAPI (DNA), Hec1 (kinetochores), GFP, and P-S44-Hec1 
(DeLuca et al., 2011). Bar, 10 µm. (B) Quantitation of data from the experi-
ment illustrated in A. Graphs report mean ± SEM. Data were normalized 
to the indicated control ratio.
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asked if restoration of Aurora B localization at inner kineto-
chores with the CENP-B–INCENP construct rescued the SAC 
defect caused by growing concentrations of 5-ITu in the pres-
ence of high doses of nocodazole (Fig. 8 A). Expression of the 
CENP-B–INCENP construct did not rescue the SAC defect 
caused by 5-ITu at any concentration tested. Indeed, expression 
of CENP-B–INCENP induced a slightly faster exit compared 
with control HeLa cells treated with the same concentration 
of 5-ITu.
In Table S1, we show that 5-ITu can target cyclin-dependent 
kinases in vitro, albeit at much higher concentrations com-
pared with Haspin (see also Discussion). To test the hypothesis 
that inhibition of Cdk1/Cyclin B may cause mitotic exit in cells 
treated with nocodazole and 5-ITu, we asked if MG132, a pro-
teasome inhibitor, antagonized the mitotic exit observed in 
these cells. By opposing the destruction of Cyclin B, MG132 
prevents mitotic exit when cells with an active SAC are chal-
lenged with a SAC inhibitor. On the other hand, MG132 is 
unable to prevent mitotic exit when cells are treated with a 
Cdk1 inhibitor, a consequence of the decline of Cdk1/Cyclin B 
expression of CENP-B–INCENP, with mean times of mitotic 
exit of 30 ± 16 min and 29 ± 12 min, respectively (Fig. 6 D). 
Thus, 5-ITu overrides the mitotic arrest caused by the expres-
sion of the CENP-B–INCENP fusion protein. Collectively, 
these results indicate that 5-ITu is a rather potent SAC inhibitor.
Forcing centromeric localization of Aurora 
B does not restore a functional SAC
Aurora B contributes to the SAC independently of its well-
established role in error correction (Kallio et al., 2002; Ditchfield 
et al., 2003; Hauf et al., 2003; Petersen and Hagan, 2003; 
King et al., 2007; Vader et al., 2007; Vanoosthuyse and Hardwick, 
2009a; Maldonado and Kapoor, 2011; Santaguida et al., 
2011; Saurin et al., 2011; Matson et al., 2012). Thus, its mis-
localization from centromeres might be sufficient for SAC 
impairment. On the other hand, the ability of 5-ITu of overrid-
ing the mitotic delay caused by expression of the CENP-B– 
INCENP suggested that 5-ITu might inhibit certain aspects of 
kinetochore signaling even when Aurora B localizes at the 
inner kinetochore region. To test this possibility formally, we 
Figure 7. Effects of 5-ITu on spindle checkpoint 
signaling. (A) Asynchronously growing HeLa 
cells were treated with 3.3 µM nocodazole. 
After 6 h, mitotic cells were isolated by shake-
off, replated, and inhibitors were added at 
the indicated concentrations under continued 
presence of nocodazole. Low-resolution live-
cell imaging was then started. Cell flattening 
indicated mitotic exit. At least 50 cells per 
condition were analyzed. (B) HeLa cells ex-
pressing H2B-Cherry were transfected with the 
CENP-B–INCENP-GFP fusion construct, and 
38 h after transfection they were exposed to 
330 nM nocodazole for 4.5 h to cause mi-
totic arrest. Mitotic cells were harvested and 
nocodazole washed out. After 50 min, cells 
were either left untreated, or were treated 
with Reversine or 5-ITu. The timing of ana-
phase onset was monitored by high-resolution 
time-lapse video microscopy. The number of 
analyzed cells is indicated.
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In an accompanying paper, Wang et al. (2012) also report a 
detailed characterization of the effects of 5-ITu, reaching 
conclusions that are almost invariably in line with ours (see 
Wang et al. in this issue).
The effects of 5-ITu on HeLa cells are consistent with 
the observed specificity of this inhibitor for Haspin in vitro 
(Tables S1 and S2; Balzano et al., 2011). Acute inhibition of 
Haspin in mitotic cells caused CPC eviction from centro-
meres and its redistribution to chromosome arms. Consistently, 
P-S7-CENP-A underwent dose-dependent removal from kineto-
chores. The kinetochore levels of the SAC proteins Bub1 and 
BubR1, as well as the levels of the P-S44-Hec1 phosphoanti-
gen were also strongly reduced, and the SAC response was 
severely weakened.
Concomitant impairment of protein phosphatase activ-
ity rescued kinetochore localization of Bub1 and BubR1. 
This suggests that centromere localization of Aurora B is re-
quired to oppose phosphatase function at centromeres and 
kinetochores, in agreement with recent studies (Emanuele et al., 
2008; Pinsky et al., 2009; Vanoosthuyse and Hardwick, 2009a,b; 
Kim et al., 2010; Liu et al., 2010; Posch et al., 2010; Foley 
et al., 2011; Lesage et al., 2011; Meadows et al., 2011; Qian 
et al., 2011; Rosenberg et al., 2011; London et al., 2012; 
activity required to maintain the mitotic state (Potapova et al., 
2006). In agreement with this notion, mitotic HeLa cells treated 
with nocodazole (3.3 µM), MG132, and the Cdk1 inhibitor flavo-
piridol exited mitosis in 30 min (Fig. 8 B).
Thus, if 5-ITu at the concentrations used in our studies in-
hibited Cdk1, then MG132 should not be able to counteract mi-
totic exit, as illustrated by flavopiridol. Treatment of HeLa cells 
with nocodazole (3.3 µM), MG132, and concentrations of 
5-ITu up to 5 µM did not cause visible effects on the timing 
of mitotic exit (monitored by measuring DNA decondensa-
tion of live HeLa cells expressing H2B-mCherry) compared 
with control cells treated only with nocodazole and MG132 
(Fig. 8 B). At 10 µM 5-ITu, an effect on the timing of mitotic 
exit (mean time of mitotic exit of 417 ± 197 min, Fig. 8 B), 
consistent with the possibility of modest Cdk1 inhibition, 
was observed.
Discussion
In this study, we extended previous analyses on the role of 
the Haspin substrate P-T3-H3 in the mitotic localization and 
activation of the CPC (Kelly et al., 2010; Wang et al., 2010; 
Yamagishi et al., 2010; F. Wang et al., 2011; Qian et al., 2011). 
Figure 8. Forcing centromeric localization of 
Aurora B does not restore a functional SAC. 
(A) HeLa cells expressing H2B-Cherry were 
transfected with CENP-B–INCENP-GFP fusion 
construct for 36 h. 7 h after addition of 3.3 
µM nocodazole, mitotic cells were isolated by 
shake-off and replated, and then the indicated 
concentrations of 5-ITu were added (or not 
added in the control). The time of mitotic exit 
was recorded by high-resolution live-cell video 
microscopy in the indicated number of cells. 
(B) Cycling HeLa cells expressing H2B-Cherry 
were treated with 3.3 µM nocodazole, and 
after 7 h mitotic cells were collected by shake-off. 
After addition of 10 µM MG132 the indicated 
drugs were added and cells were filmed by 
low-resolution time-lapse video microscopy. At 
least 50 cells per condition were analyzed.
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realistic localization conditions that mimic more effectively the 
localization of the endogenous protein.
Although we previously excluded known checkpoint 
kinases as targets of 5-ITu in vitro (Balzano et al., 2011), it 
remains possible that the adverse effects of 5-ITu on the SAC 
may result from off-target inhibition of a different SAC compo-
nent. Besides setting the stage for the execution of mitosis, 
Cdk1 is also considered important for the SAC (D’Angiolella 
et al., 2003; Wong and Fang, 2007; Morin et al., 2012). In our 
previous studies, where 5-ITu was tested at 1 µM, we failed 
to observe inhibition of Cdk1/Cyclin B activity with 5-ITu 
(Balzano et al., 2011). Discrepancy with analyses described 
here (Tables S1 and S2) might be due to differences in the prep-
aration of kinase samples for the in vitro assay. A comparison 
of the experiments displayed in Figs. 7 A and 8 B, however, 
suggest that inhibition of Cdk1 is not a major concern in the 
interpretation of the effects of 5-ITu at the concentrations 
used in this study. Specifically, the much longer mitotic delay 
in the presence of MG132 in these experiments strongly sug-
gests that Cdk1 is not a crucial target in the SAC override 
effects of 5-ITu.
The effects of 5-ITu on localization of Aurora B substrates 
were invariably rescued by the CENP-B–INCENP construct, 
but those on the SAC were not, even at intermediate concentra-
tions of 5-ITu. A possible interpretation of this is that Haspin 
itself is required for an aspect of SAC signaling distinct from 
centromere and kinetochore localization of Aurora B and other 
proteins whose localization is controlled by Aurora B. Alterna-
tively, 5-ITu might be inhibiting a distinct SAC pathway, in ad-
dition to that represented by the Haspin–Aurora B axis. Future 
studies will have to address this issue in detail.
Due to its function as a regulator of Aurora B, Haspin is 
recognized as a potential target for pharmacological interven-
tion in anti-tumor therapy (Patnaik et al., 2008; Cuny et al., 
2012; Huertas et al., 2012). Characterization of 5-ITu as a 
Haspin inhibitor discussed here will provide the research com-
munity with a readily available, public domain inhibitor for 
chemical biology investigations of this important kinase.
Materials and methods
Mammalian plasmids and cell lines
To express the CENP-B(1–158)-INCENP(47–920)-GFP construct in HeLa 
cells we used the SL417 vector, which was obtained from the pEGFP-N1 
backbone [SL417 was provided by S.M.A. Lens, University Medical 
Center, Utrecht, Netherlands, who has previously provided a detailed de-
scription of this vector (Liu et al., 2009)]. The CENP-BAAA mutant (Arg5-Ala, 
Lys70-Ala, Arg125-Ala) was obtained by site-directed mutagenesis using 
the following primers: R5A_F (5-TTCGGCCCCAAGGCGCGACAGCTGAC-
GTTC-3), R5A_R (5-GAACGTCAGCTGTCGCGCCTTGGGGCCGAA-
3), K70A_F (5-TGCCGCAAGACCAACGCGCTGTCTCCCTACGAC-3), 
K70A_R (5-GTCGTAGGGAGACAGCGCGTTGGTCTTGCGGCA-3), 
R125A_F (5-GGCTGGCTGGACGCCTTCCGCCGGCGCCAC-3), and 
R125A_R (5-GTGGCGCCGGCGGAAGGCGTCCAGCCAGCC-3). HeLa 
cells stably expressing H2B-Cherry used in high-resolution time-lapse ex-
periments were a gift of Sara Barozzi (Imaging Facility, IFOM-IEO Cam-
pus, Milan, Italy).
Cell culture and transfection
HeLa cells were grown in DME (Euroclone) supplemented with 10% fetal 
bovine serum (FBS, Hyclone) and 2 mM l-glutamine. Nocodazole (Sigma-
Aldrich) was used at a concentration of 3.3 µM unless differently specified. 
Shepperd et al., 2012). Consistently, kinetochore localization of 
Bub1 and BubR1 in 5-ITu was also rescued by a kinetochore-
targeting CENP-B–INCENP construct, but not by an equiva-
lent construct impaired in DNA binding. PP1-targeting motifs 
conforming to the Arg-Val-Ser/Thr-Phe (RVS/TF) consensus 
(Hendrickx et al., 2009) can be phosphorylated by Aurora B 
to counteract PP1 binding (Kim et al., 2010; Liu et al., 2010; 
Lesage et al., 2011; Meadows et al., 2011; Rosenberg et al., 
2011), and it is plausible that PP1 activity prevails at kineto-
chores when Aurora B localization is perturbed.
We documented the effects of 5-ITu over a range of con-
centrations. For the localization experiments, we opted for the 
10-µM 5-ITu concentration because the effects on Aurora B 
substrates at kinetochores (P-S7–CENP-A and P-S44–Hec1) 
become especially evident at this concentration. Such effects 
were invariably rescued by ectopic Aurora B localization me-
diated by CENP-B–INCENP. We therefore assume that the 
effects of 5-ITu, at least for what concerns the localization of 
phosphoantigens and SAC proteins that depend on Aurora B 
for their appearance at kinetochores, are caused exclusively 
by Aurora B mislocalization. It may seem puzzling that the 
decrease in the centromeric levels of Aurora B becomes ap-
parent at lower concentrations of 5-ITu (Fig. 2 A) than those 
required for the eviction of kinetochore phosphoantigens at-
tributed to Aurora B (e.g., P-S7–CENP-A in Fig. 3 A). This 
observation might reflect a nonlinear relationship between 
the levels of Aurora B and its kinase output, so that even 
very small residual amounts of Aurora B might be sufficient 
to phosphorylate kinetochore substrates.
When using 5-ITu at a concentration of 10 µM we failed 
to observe an obvious decrease in the levels of P-S10-H3 in 
immunofluorescence experiments (Fig. 3). Western blot analy-
sis of cell lysates, however, demonstrated a noticeable decrease 
of the P-S10-H3 signal in cells treated with 10 µM 5-ITu (Fig. S2). 
Although we are at present unable to provide a conclusive ex-
planation for such a discrepancy, we infer that it might reflect 
the presence of a nonmitotic fraction of cells in the population 
subjected to Western blot analysis. At 10-µM concentration, 
5-ITu forced mitotic exit in the presence of nocodazole and 
MG132, possibly indicative of partial Cdk1 inhibition (Fig. 8 B). 
However, this effect typically manifested itself on average 
400 min after addition of 5-ITu, whereas cells were harvested 
for Western blot analysis only 90 min after addition of 5-ITu. 
Future studies will have to address this issue in greater depth.
Given the importance of kinetochore localization of Bub1 
and BubR1 for their SAC function, our observations are consis-
tent with the idea that centromere localization of Aurora B is 
necessary for SAC function (E. Wang et al., 2011). However, 
we failed to observe significant rescue of the checkpoint defect 
caused by 5-ITu simply by targeting Aurora B to the kineto-
chore with a CENP-B–INCENP construct. Failure to rescue the 
adverse effects of 5-ITu on the SAC might indicate that the 
CENP-B–INCENP construct does not fully recapitulate Aurora B 
localization. For instance, recent studies identified the active 
form of Aurora B specifically at kinetochores (Posch et al., 
2010; DeLuca et al., 2011; Petsalaki et al., 2011). Targeting 
Aurora B to other kinetochore domains might provide more 
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and Genetics, Dresden, Germany) were treated for 12 h with 3.3 µM no-
codazole, incubated with 10 µM MG132 for 30 min and then treated with 
the indicated drugs for 90 min. Mitotic cells were harvested by shake-off, 
incubated for 20 min in 75 mM KCl, 3.3 µM nocodazole, MG132 10 µM 
and the indicated drugs, and then dropped on a coverslip to be pro-
cessed for immunofluorescence. Primary antibodies used were: rabbit anti 
phospho-H3-Thr3 (1:75); rabbit anti-phospho-CENP-A-Ser7 (1:300); and 
human anti-centromeric antibodies (1:50). Images were acquired on a con-
focal microscope (model TCS SP2; Leica) equipped with a 100× NA 1.4 
objective lens and using LCS 3D software (Leica).
Live-cell imaging
For high-resolution live-cell imaging, cells were plated after mitotic shake-
off onto Lab-Tek II chambered coverglasses (Thermo Fisher Scientific) 
coated with 15 µg/ml poly-d-lysine (Sigma-Aldrich), in DME without phe-
nol red (Gibco). Live-cell imaging was performed using a DeltaVision 
Elite imaging system (Applied Precision) with an inverted microscope 
(model IX71; Olympus), a PlanApo 60× (1.42 NA) oil immersion objec-
tive (Olympus), and a CoolSNAP HQ2 camera (Photometrics). The sys-
tem was equipped with an environmental chamber maintained at 37°C 
in an atmosphere of 5% CO2. Images were acquired as z-stacks (1.5-µm 
step) and converted into maximal intensity projections using ImageJ. For 
low-resolution live-cell imaging cells were plated after mitotic shake-off 
onto 12-well plastic dishes coated with 15 µg/ml poly-d-lysine. Imaging 
was performed using a ScanR system (Olympus) equipped with an in-
verted microscope (model IX70; Olympus) using 20× (0.45 NA) or 40× 
(0.6 NA) dry objectives and an ORCA-ER camera (Hamamatsu Photonics). 
Cells were maintained at 37°C and 5% CO2 in a humidified incubation 
chamber (Solent Scientific).
Online supplemental material
Fig. S1 shows additional points of concentration series for experiments 
displayed in Fig. 1 and Fig. 2. Fig. S2 reports Western blots that comple-
ment observations displayed in Fig. 3. Fig. S3 reports additional localiza-
tion experiments that complete the series shown in Fig. 5. Fig. S4 reports 
additional quantitation experiments that complete the series shown in Fig. 5. 
Fig. S5 reports additional experiments related to Fig. 7 B. Tables S1 and 
S2 report 5-ITu inhibition data for two sets of kinases in two distinct assays. 
Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.201205119/DC1.
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Immunofluorescence
HeLa cells were plated onto coverslips coated with 15 µg/ml poly-d-lysine 
(Sigma-Aldrich). Cells were fixed using 4% PFA in PBS, permeabilized using 
0.1% Triton X-100 in PBS, then treated with 4% BSA in PBS as a blocking 
agent and incubated with the appropriate antibodies diluted in 4% BSA in 
PBS. Alternatively cells were fixed through incubation with 4% paraformal-
dehyde in PHEM buffer, pH 7.0 (100 mM Pipes, 50 mM Hepes, 20 mM 
EGTA, and 16 mM MgSO4) for 20 s, followed by incubation in PHEM con-
taining 0.5% Triton X-100 for 5 min, and by further 10 min fixation with 
4% paraformaldehyde in PHEM. For Fig. 6, cells were fixed as above but 
for 20 min, then treated with PHEM containing 1% Triton X-100 for 5 min 
and prepared for antibody staining. The following antibodies were used 
for immunofluorescence: anti-centromeric antibody (working dilution 1:50–
1:100; Antibodies Inc.), mouse anti Hec1 (clone 9G3.23, working dilu-
tion 1:1,000; Genetex), mouse anti–-tubulin (clone B512, working 
dilution 1:2,000; Sigma-Aldrich), mouse anti-Borealin (M147-3, work-
ing dilution 1:200; MBL International), rabbit anti-Aurora B (AB2254, 
working dilution 1:1,000; Abcam), mouse anti-phospho-H3 Ser10 (work-
ing dilution 1:1,000; Abcam), rabbit anti-phospho-CENP-A-Ser7 (04–792, 
working dilution 1:200–1:300; EMD Millipore); rabbit anti-phospho-H3-
Thr3 (9714S, working dilution 1:50–1:100; Cell Signaling Technology). 
Sheep anti-Bub1 (residues 336–489) and sheep anti-BubR1 (residues 2–211; 
a gift from S. Taylor, University of Manchester, Manchester, UK; working dilu-
tion 1:1,000 for both) and rabbit P-S44-Hec1 (a gift from J. DeLuca, Colo-
rado State University, Fort Collins, CO; working dilution 1:3,000) have been 
described previously (Taylor et al., 2001; Tighe et al., 2008; DeLuca et al., 
2011). Cy3-, RhodamineRed-X–, Cy5-, and DyLigth649-conjugated second-
ary antibodies were purchased from Jackson ImmunoResearch Laboratories. 
Alexa 488–labeled secondary antibodies were from Invitrogen. DNA was 
stained with DAPI. The coverslips were mounted using Mowiol mounting 
media or ProLong Gold Antifade reagent (Life Technologies). Cells were 
imaged at 25°C using a confocal microscope (model TCS SP2; Leica) 
equipped with a 63× NA 1.4 objective lens and using LCS 3D software 
(Leica) or, alternatively, using a DeltaVision Elite imaging system (Applied 
Precision) and microscope (model IX-71; Olympus) controlled by SoftWoRx 
software (Applied Precision) and a 100× 1.49 NA objective lens with a 
CoolSNAP HQ2 camera (Photometrics). Images were acquired as z-sections 
at 0.2442 µm (SP2; Leica) or 0.3 µm (DeltaVision), respectively, and con-
verted into maximal intensity projections using ImageJ (National Institutes of 
Health) or SoftWoRx (Applied Precision) software. Deconvolution was per-
formed using a constrained-iterative algorithm in SoftWoRx.
Quantitation of immunofluorescence data
Quantitation of immunofluorescence was performed using SoftWoRx. Pixel 
intensity was measured for each channel within a mask encompassing in-
dividual kinetochores; the average background pixel intensity was mea-
sured from three different cytosolic regions. After background subtraction, 
kinetochore signals were normalized to CREST (with the exception of 
P-S44-Hec1, where the signal was normalized to Hec1). Data analysis was 
performed using Prism 5.0 (GraphPad Software); final figures were assem-
bled in Illustrator CS5.1 (Adobe). Graphs show mean ± SEM from at least 
two independent experiments. 18–20 kinetochores from 5–6 cells were 
used in each case.
Chromosome spreads
HeLa cells stably expressing mouse-Aurora B-LAP (MCB 73, a gift of 
I. Poser and A.A. Hyman, Max Planck Institute of Molecular Cell Biology 
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